Back
Vertex Pharmaceuticals Stock Price Chart
Sponsored
3 A.I.-Predicted Stocks to Add to Your Portfolio
Watch Live & FREE Thriving Trends Forecasted by This A.I. Now
Buy
57
VRTX
Vertex Pharmaceuticals
Last Price:
334.72
Seasonality Move:
7.13%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
This color-coded "trading stoplight" keeps you in the right lane
CLICK TO WATCH- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 329.52 | Buy |
| 20-day SMA: | 338.86 | Sell |
| 50-day SMA: | 331.38 | Buy |
| 200-day SMA: | 306.9 | Buy |
| 8-day EMA: | 330.56 | Buy |
| 20-day EMA: | 334.32 | Sell |
| 50-day EMA: | 329.47 | Buy |
| 200-day EMA: | 306.21 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 49.64 | Sell |
| Chaikin Money Flow: | 1364081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (331.94 - 348.2) | Sell |
| Bollinger Bands (100): | (295.99 - 334.97) | Buy |
Vertex Pharmaceuticals Technical Analysis
| May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 333.78 while VRTX 8-day simple moving average is 329.52, which is a Buy signal.
- The stock price of VRTX is 333.78 while Vertex Pharmaceuticals 20-day SMA is 338.86, which makes it a Sell.
- Vertex Pharmaceuticals 50-day simple moving average is 331.38 while VRTX share price is 333.78, making it a Buy technically.
- VRTX stock price is 333.78 and Vertex Pharmaceuticals 200-day simple moving average is 306.90, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
57
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $333.78. The Score for VRTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
85.97B
Price in USD:
333.78
Share Volume:
1.55M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
354.46
52-Week Low:
243.17
Buy
57
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 333.78 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 333.78 while VRTX 8-day exponential moving average is 330.56, which is a Buy signal.
- The stock price of VRTX is 333.78 while Vertex Pharmaceuticals 20-day EMA is 334.32, which makes it a Sell.
- Vertex Pharmaceuticals 50-day exponential moving average is 329.47 while VRTX share price is 333.78, making it a Buy technically.
- VRTX stock price is 333.78 and Vertex Pharmaceuticals 200-day simple moving average is 306.21, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.28 per share, an increase next quarter of $0.20 per share, a decrease this year of $0.02 per share, and an increase next year of $1.44 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -1.65, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 49.64, which suggest Vertex Pharmaceuticals is oversold
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (331.94 - 348.2), which suggest Vertex Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (295.99 - 334.97), which suggest Vertex Pharmaceuticals is a Buy
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.